Skip to main content

MoneyWorks4Me

Venus Remedies informs about press release

26 Oct 2023 Evaluate

Venus Remedies has informed that it enclosed a press release being issued by the Company titled ‘Venus Remedies Granted Market Authorization for Bleomycin 15,000 IU in the united Kingdom’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1758.00
Dr. Reddys Labs. 1335.40
Cipla 1360.00
Lupin 1971.00
Zydus Lifesciences 1172.00
View more..